Company intelligence / Profile preview

Atley Solutions

Gothenburg, Västra Götaland County, Swedenatley.com ↗

Ownership: Private
Development stage: Commercial

Overview

Atley Solutions has developed and commercialized the world’s first automated, GMP-compliant module—Atley C100—for scalable production of astatine‑211-based radiopharmaceuticals. Their technology enables reliable supply and clinical translation of targeted alpha therapies, with a focus on supporting drug developers in oncology. The company is not a direct developer of therapeutics but provides essential infrastructure to enable clinical trials and commercialization by others[1][2][6].

Therapeutic areas: Oncology
Modalities: RadiopharmaceuticalSmall molecule
Industry: Contract Manufacturing Organization

Partnerships

Nusano (collaboration to co-develop supply chains for astatine‑211 radiopharmaceuticals in oncology therapeutics)

Beyond the preview

Go deeper on Atley Solutions.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Atley Solutions.

Explore the full profile